Publication | Closed Access

A prospective placebo-controlled double-blind multicenter trial of intravenous streptokinase in acute myocardial infarction (ISAM): Long-term mortality and morbidity

ThrombosisIntravenous StreptokinaseCardiovascular DiseaseLong-term MortalityPharmacotherapyAcute Myocardial InfarctionMedicineCardiologyIschemic SyndromeEmergency MedicineCoronary Artery DiseaseMyocardial Infarction